Nutrition support in adults
Everything NICE has said on nutrition support for adults who are malnourished or at risk of malnutrition in an interactive flowchart
Search results
627 results
-
-
Antimicrobial prescribing: cefiderocol (ES31)
Summary of the evidence on antimicrobial prescribing: cefiderocol
-
Shared Learning Awards 2020: Winner announced
Virtual ceremony sees a project from Avon and Wiltshire Mental Health Partnership Trust voted winning submission
-
Attachment difficulties in children and young people
Everything NICE has said on identifying, assessing and treating attachment disorders in under 18s in an interactive flowchart
-
Food allergy in under 19s
Everything NICE has said on diagnosing and assessing food allergy in children and young people in primary care and community settings in an interactive flowchart
-
Developmental follow-up of children and young people born preterm
Everything NICE has said on developmental follow-up of children and young people born preterm in an interactive flowchart
-
Innovative technology to detect abnormal heart rhythms recommended by NICE for NHS use while further data is collected
Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to be recommended for NHS use with the caveat that further data must be collected.
-
Perioperative care
Everything NICE has said on perioperative care in adults in an interactive flowchart.
-
Transient loss of consciousness
Everything NICE has said on assessing, diagnosing and referring adults and young people who have experienced a blackout in an interactive flowchart
-
Atrial fibrillation
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
-
Foot care for people with diabetes
Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart
-
Antimicrobial stewardship
Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart
-
Pneumonia
Everything NICE has said on assessing and managing community- and hospital-acquired pneumonia in an interactive flowchart
-
Leg ulcers
Everything NICE has said on leg ulcers in an interactive flowchart
-
How NICE is improving patient safety
Annual patient safety update covers the period from September 2019 to September 2020
-
Upper aerodigestive tract cancer
Everything NICE has said on assessing and managing upper aerodigestive tract cancer in young people and adults in an interactive flowchart
-
Lung cancer
Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart
-
Prostate cancer
Everything NICE has said on diagnosing and treating prostate cancer in an interactive flowchart
-
New option for people with difficult-to-treat multiple myeloma is recommended for use in Cancer Drugs Fund by NICE
Around 5,700 cases of multiple myeloma are diagnosed each year in the UK
-
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
NICE has developed a medtech innovation briefing (MIB) on QuickChange Incontinence Wrap for urinary incontinence in men
-
Drug misuse management in over 16s
Everything NICE has said on psychosocial interventions and opioid detoxification for drug misuse in an interactive flowchart
-
Drug allergy
Everything NICE has said on diagnosing and managing drug allergy in an interactive flowchart
-
Spasticity in children and young people
Everything NICE has said on managing spasticity and co-existing motor disorders in children and young people in an interactive flowchart
-
Ectopic pregnancy and miscarriage
Everything NICE has said on diagnosing and managing tubal ectopic pregnancy and miscarriage in early pregnancy in an interactive flowchart.
-
Musculoskeletal conditions
Everything NICE has said on musculoskeletal conditions in an interactive flowchart
-
Bronchiectasis (non-cystic fibrosis) – antimicrobial prescribing
Everything NICE has said on antimicrobial prescribing for managing and preventing an acute exacerbation of bronchiectasis (non-cystic fibrosis) in an interactive flowchart
-
NICE is getting ready for the end of the transition period after Brexit
NICE has a key role in evaluation and access to new and innovative products for the health system, playing an important role in ensuring the UK remains a destination of choice for the life sciences sector.
-
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions: coronary heart disease, heart failure, hypertension, diabetes, CKD, PAD, or stroke/TIA who have had a pulse rhythm assessment in the preceding 12 months.
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions:...
-
The percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if ACE-I intolerant), aspirin (or clopidogrel) (or anticoagulant drug therapy) and a statin and a beta-blocker for those patients with left ventricular systolic dysfunction
The percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if...
-
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 12 months (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more)
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring...
-
The percentage of patients who had a myocardial infarction in the preceding 1 April to 31 March and who are currently being treated with ACE-I (or ARB if ACE-I intolerant), dual anti-platelet therapy, a statin and a beta blocker for those patients with left ventricular systolic dysfunction
The percentage of patients who had a myocardial infarction in the preceding 1 April to 31 March and who are currently being treated with ACE-I (or ARB
-
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or
-
Physical activity
Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart
-
Headaches
Everything NICE has said on the most common primary headache disorders in young people aged 12 years and older and adults in an interactive flowchart
-
Health of people in the criminal justice system
Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system
-
Familial hypercholesterolaemia
Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart
-
Acute coronary syndromes: secondary prevention and rehabilitation
Everything NICE has said on secondary prevention and rehabilitation following acute coronary syndromes in an interactive flowchart
-
Behaviour change
Everything NICE has said on changing people's health-related behaviours, including interventions aimed at over 16s, in an interactive flowchart
-
Multiple sclerosis
Everything NICE has said on multiple sclerosis in an interactive flowchart
-
Myeloma
Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart
-
Acute coronary syndromes: early management
Everything NICE has said on the early management of coronary syndromes in an interactive flowchart
-
World Antimicrobial Awareness Week: developing new models for the evaluation and purchase of antimicrobials
Nick discusses World Antimicrobial Awareness Week and an important project he’s involved with to develop new models for the evaluation and purchase of antimicrobials.
-
Chest pain
Everything NICE has said on assessing and diagnosing recent-onset chest pain of suspected cardiac origin and managing stable angina in an interactive flowchart
-
Magseed for locating impalpable breast cancer lesions (MIB236)
NICE has developed a medtech innovation briefing on Magseed for locating impalpable breast cancer lesions
-
NICE recommends innovative treatment for severe blood disorder for NHS use
Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.
-
Inadvertent perioperative hypothermia
Everything NICE has said on preventing and managing inadvertent perioperative hypothermia in adults having surgery in an interactive flowchart
-
How NICE guidance and resources can be used to evidence continuing professional development (CPD)
Registered social workers must demonstrate the use of evidence and research to inform their practice in order to meet professional standards. This is echoed in Social Work England’s continuing professional development (CPD) standards.
-
NPi-200 for pupillary light reflex in critical care patients (MIB235)
NICE has developed a medtech innovation briefing on NPi-200 for pupillary light reflex in critical care patients
-
NICE draft guidance addresses the continuing debate about the best approach to the diagnosis and management of ME/CFS
NICE has today (10 November 2020) published its draft updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
-
Cardiovascular disease prevention
Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults